Navigating the Post-Relapse Precipice: Head-to-Head Study Weighs Therapeutic DLI Against Second Allogeneic Transplants in Blood Cancers
Executive Overview For decades, disease relapse following an allogeneic hematopoietic cell transplantation (allo-HCT)—the high-stakes curative procedure for acute leukemias and myelodysplastic syndromes (MDS)—has represented one of the most disheartening outcomes…